Nxera
nxera.life
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
At Nxera Pharma, our mission is to accelerate the development of life-changing medicines by investing in science and technology. Our world-leading and proprietary NxWave™ platform enables us to unlock the potential of GPCRs to rational structure-based drug design and develop life-changing medicines.
News
Nxera to Book US$10m Milestone as FDA Clears Phase 2 Alzheimer's Drug
Tipranks Press Release.
Read more
Report
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
Tokyo, Japan and Cambridge, UK, 7August 2026 - Nxera Pharma (
Read more
Report
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
New company (
Read more
Report
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
New company (
Read more
Report
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
Tokyo, Japan and Cambridge, UK, 12 February 2026 - Nxera Pharma Co., Ltd. (
Read more
Report
Singtel's Nxera and partners to hire over 500 people for digital, data centre roles
They will hire fresh graduates and mid-career professionals in technical and non-technical functions such as data centre consultancy, design, engineering, operations and sustainability.
Read more
Report
NeutraDC Nxera Batam and Medco Power join efforts to deliver renewable energy for AI enabler data center
Read more
Report
Nxera Pharma Announces Supply And Distribution Deal With Handok For PIVLAZ In South Korea
(RTTNews) - Nxera Pharma Co. Ltd, formerly known as Sosei Group, announced that its operating business Nxera Pharma Korea has reached an exclusive supply and distribution agreement with Handok Inc. to commercialize PIVLAZ (clazosentan sodium) 150 mg in So
Read more
Report